PIF’s Joint Venture with Hyundai Motor Company, Hyundai Motor Manufacturing Middle East, celebrates groundbreaking milestone
Paving the way for a new industrial future The new facility is a joint venture between PIF and Hyundai Motor Company The plant will manufacture internal combustion... Read more.
AGNICO EAGLE ANNOUNCES ADDITIONAL INVESTMENT IN FORAN MINING CORPORATION
Stock Symbol: AEM (NYSE and TSX) TORONTO, May 14, 2025 /PRNewswire/ – Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) (“Agnico Eagle”) announced... Read more.
Waystar Announces Pricing of Public Offering of Common Stock
LEHI, Utah and LOUISVILLE, Ky., May 14, 2025 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY) (“Waystar”), a provider of leading healthcare... Read more.
EVA Air to Launch Exciting Upgrade for Inflight Wi-Fi Service this July
TAIPEI, Taiwan, May 14, 2025 /PRNewswire/ — EVA Air is set to launch a significant upgrade to its in-flight Wi-Fi service this July, offering complimentary... Read more.
WILDBRAIN REPORTS Q3 2025 RESULTS
Q3 Operational Highlights Strong growth in Global Licensing with a 44% year-over-year increase, driven by our premium franchises Peanuts, Strawberry Shortcake and... Read more.
FDA Extends PDUFA Date of Biohaven’s Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
– Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. – Troriluzole has been granted... Read more.
WindRose Health Investors Completes the Sale of Workplace Options to TELUS Health
NEW YORK, May 14, 2025 /PRNewswire/ — WindRose Health Investors, LLC (“WindRose”), the New York-based healthcare private equity firm, announced... Read more.
B-29 DOC History Restored Tour to Land at Hagerstown Aviation Museum
HAGERSTOWN, Md., May 14, 2025 /PRNewswire/ — The B-29 DOC History Restored Tour will land at Hagerstown Aviation Museum with P-51 Mustang Gunfighter, May 27... Read more.
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Presentation Covers Aspen’s Autologous iPSC-derived Approach for Neuron Replacement Therapy in Trial for Parkinson’s Disease SAN DIEGO, May 14, 2025... Read more.
Thayer Ventures Acquisition Corporation II Announces Pricing of $175 Million Initial Public Offering
VALENCIA, Calif., May 14, 2025 /PRNewswire/ — Thayer Ventures Acquisition Corporation II (the “Company“), a special purpose acquisition company,... Read more.